The Global Chronic Kidney Disease (CKD) Drugs market reached $12.2bn in 2016

LONDON, Fev. 5, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5308400



Report Details
The Global Chronic Kidney Disease (CKD) Drugs market reached $12.2bn in 2016 and is expected to grow at a CAGR of 3.9% in the first half of the forecast period. The market is dominated by calcium channel blockers and ACE inhibitors.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 171-page report you will receive 85 tables and 93 figures – all unavailable elsewhere.
The 171-page report provides clear detailed insight into the Global Chronic Kidney Disease (CKD) Drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
• Global Chronic Kidney Disease (CKD) Drugs market forecasts from 2018-2028

This report also breaks down the revenue forecast for the Global Chronic Kidney Disease (CKD) Drugs market by drug class:
- ACE inhibitors
- Angiotensin-II receptor blockers
- Calcium channel blockers
- Beta blockers: BREVIBLOC, Bystolic
- Erythropoiesis-stimulating agents (ESAs)
- Diuretics
- Others

This report provides a SWOT Analysis for each drug class.

This report provides revenue forecast for these leading drugs:
- Aceon
- Lisinopril
- Losartan
- AVAPRO
- Twynsta
- BREVIBLOC
- Bystolic
- Mircera
- Epoetin Alfa BS
- Natrilix SR
- Spironolactone
- Urief
- AURYXIA

This report also breaks down the revenue forecast for the Global Chronic Kidney Disease (CKD) Drugs market by distribution channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others

This report also breaks down the revenue forecast for the Global Chronic Kidney Disease (CKD) Drugs market by regional and national market:
- North America: US and Canada
- Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
- Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
- Latin America: Brazil, Mexico, Rest of Latin America
- Middle East & Africa: Saudi Arabia, South of Africa, Rest of MEA

Each regional market is further broken down by drug class and distribution channel.

This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the Global Chronic Kidney Disease (CKD) Drugs market:
- Pfizer, Inc.
- Amgen
- Roche
- GlaxoSmithKline (GSK)
- Allergan
- AbbVie
- Kissei Pharmaceutical Co., Ltd.

Buy our report today Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028: ACE inhibitors, angiotensin-II receptor blockers, calcium channel blockers, beta blockers, erythropoiesis-stimulating agents (ESAs), diuretic, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Download the full report: https://www.reportbuyer.com/product/5308400

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com  

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com